FQU-17782-04863
4 vaccinations
4 coded responses
51 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 483 / MI
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Registered in v-safe
-
2021-03-22
Dose 1 — Pfizer-BioNTech
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-04-05
-
2021-04-12
Dose 2 — Pfizer-BioNTech
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-05-17
- 2021-05-26
-
2021-07-12
Survey response — 3 months, dose 2MedDRA: Cardiac disorder, Cardiac operation, Dyspnoea, Fatigue, Unevaluable event — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Symptoms: Shortness of breath, tired. Found several congenital heart defects and had open heart surgery. NOT VACCINE RELATED · Healthcare visit (other): Ekg, echo, stress test, 6 minute walk test, pulmonary breath test, CT, chest x-ray, MRI/MRA, coronary CT, open heart surgeryMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-12
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-21
Call successfulParticipant prefers to complete VAERS report online
-
2021-10-11
Survey response — 6 months, dose 2MedDRA: Cardiac operation, Pre-existing disease, Pulmonary arterial hypertension — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Heart surgery for congenital defects and Pulmonary Arterial Hypertension. NOT RELATED TO THE VACCINEMedDRA releases: 2024-11 · check-in free text available
-
2021-10-14
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-10-15
Survey response — days 1–6 daily, dose 3MedDRA: Back pain — Feeling: Poor · Muscle or body aches, Fatigue or tirednessFree text: horrible back painMedDRA releases: 2024-11 · check-in free text available
- 2021-10-16
- 2021-10-17
- 2021-10-18
- 2021-10-19
- 2021-10-20
- 2021-10-22
- 2021-10-28
- 2021-11-04
-
2021-11-11
Survey response — day 28, dose 3MedDRA: Cough, Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Common cold. Runny nose, then congestion with a light cough at the end.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-18
- 2021-11-25
- 2022-01-13
- 2022-04-14
-
2022-09-28
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-29
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-04
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-03
- 2022-11-09
- 2022-12-28
- 2023-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Pfizer-BioNTech | |
| 2 | 2021-04-12 | Pfizer-BioNTech | |
| 3 | 2021-10-14 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-28 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 successful
Free text
Release 9 — 3 months, dose 2
Symptoms: Shortness of breath, tired. Found several congenital heart defects and had open heart surgery. NOT VACCINE RELATED
Healthcare visit (other): Ekg, echo, stress test, 6 minute walk test, pulmonary breath test, CT, chest x-ray, MRI/MRA, coronary CT, open heart surgery
Release 10 — 6 months, dose 2
Symptoms: Heart surgery for congenital defects and Pulmonary Arterial Hypertension. NOT RELATED TO THE VACCINE
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): horrible back pain
Release 10 — day 28, dose 3
Symptoms: Common cold. Runny nose, then congestion with a light cough at the end.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Cardiac disorder | ✓ | ✓ | ✓ |
| SD | Cardiac operation | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pulmonary arterial hypertension | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Back pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release